Chris Wright is the first participant in the trial. Chris developed Tourette syndrome in childhood and despite medication, his condition has persisted. Some people with Tourette syndrome experience side-effects to existing therapies including fatigue and weight gain.
At 31, Chris is working full-time in a customer service position in Brisbane and spends his day trying to regulate his tics. “Any reprieve would be very welcome. It is getting to the point where I don’t know what to do, it feels as though it all gets too much sometimes,” said Chris.
Participants in the clinical trial at Wesley Medical Research will complete two six-week “crossover” periods of treatment with active drug or placebo, with both participants and investigators unaware of treatment status until the trial is complete.
“Tourette syndrome has really been a blow to my confidence … my life in general, I often spend my days off sleeping and recovering just to do it all again,” Chris said.